Phase I trial to evaluate safety, pharmacokinetics, and efficacy of sorafenib combined with docetaxel in patients with advanced, refractory solid tumors

被引：0
|
作者：
Awada, A.
Hendlisz, A.
Whenham, N.
Gil, T.
Christensen, O.
Lathia, C.
Bartholomeus, S.
Delabaye, I.
De Valeriola, D.
Brendel, E.
Delaunoit, T.
Piccart, M.
机构：
[1] Jules Bordet Inst, Brussels, Belgium
[2] Bayer Pharmaceut Corp, West Haven, CT USA
[3] Bayer HealthCare, Wuppertal, Germany
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：39 / 39
页数：1
相关论文
共 50 条
  • [41] A phase I trial of sorafenib combined with cisplatin/etoposide or carboplatin/pemetrexed in refractory solid tumor patients
    Davies, Janine M.
    Dhruva, Nirav S.
    Walko, Christine M.
    Socinski, Mark A.
    Bernard, Stephen
    Hayes, D. Neil
    Kim, William Y.
    Ivanova, Anastasia
    Keller, Kimberly
    Hilbun, Layla R.
    Chiu, Michael
    Dees, E. Claire
    Stinchcombe, Thomas E.
    LUNG CANCER, 2011, 71 (02) : 151 - 155
  • [42] Phase I study of docetaxel and ifosfamide in patients with advanced solid tumors
    Pronk, L
    Shrijvers, D
    LocciTonelli, D
    Verweij, J
    VanOosterom, AT
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 961 - 961
  • [43] Phase I evaluation of docetaxel and topotecan for patients with advanced solid tumors
    Tsao, AS
    Shin, DM
    Palmer, JL
    Lee, JS
    Glisson, BS
    CANCER, 2004, 100 (10) : 2240 - 2245
  • [44] Phase I study on docetaxel and Gemcitabine in patients with advanced solid tumors
    Jaremtchuk, AV
    Zarba, JJ
    Ferro, A
    ANNALS OF ONCOLOGY, 1998, 9 : 138 - 139
  • [45] Phase I study to determine the safety and pharmacokinetics of BAY 43-9006 in patients with advanced refractory solid tumors.
    Hirte, H
    Moore, MJ
    Oza, AM
    Siu, LL
    Harris, H
    Maclean, M
    Petrenciuc, O
    Fiander, W
    Lathia, C
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3768S - 3768S
  • [46] A phase I/II, open-label, multicenter study to evaluate the safety, pharmacokinetics, pharmacodynamics, and efficacy of HB0036 in patients with advanced solid tumors
    Sun, Yuping
    Yu, Jinming
    Tolcher, Anthony W.
    Albany, Costantine
    Chaudhry, Arvind
    Dang, Qi
    Ye, Leiguang
    Yang, Fang
    Liu, Baogang
    Sun, Longhua
    Tang, Jianjun
    Xu, Lei
    Zhu, Xiangyang
    Yang, Yongmin
    Yang, Yang
    Zhan, Yifan
    Li, Benke
    Hou, Kexin
    Zheng, Yang, Sr.
    Wang, Jingjing
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [47] Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors
    Soria, J. -C.
    DeBraud, F.
    Bahleda, R.
    Adamo, B.
    Andre, F.
    Dientsmann, R.
    Delmonte, A.
    Cereda, R.
    Isaacson, J.
    Litten, J.
    Allen, A.
    Dubois, F.
    Saba, C.
    Robert, R.
    D'Incalci, M.
    Zucchetti, M.
    Camboni, M. G.
    Tabernero, J.
    ANNALS OF ONCOLOGY, 2014, 25 (11) : 2244 - 2251
  • [48] A phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors
    Soria, Jean-Charles
    De Braud, Filippo G.
    Bahleda, Ratislav
    Adamo, Barbara
    Cereda, Roberta
    Camboni, Maria Gabriella
    Robert, Renate
    Isaacson, Jeffrey D.
    Litten, Jason B.
    Allen, Andrew R.
    Rolfe, Lindsey
    Tabernero, Josep
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [49] A phase I trial to determine the maximum tolerated dose and evaluate the safety and pharmacokinetics (PK) of docetaxel-PNP, polymeric nanoparticle formulation of docetaxel, in subjects with advanced solid malignancies
    Jung, Kyung Hae
    Kim, Kyu-Pyo
    Yoon, Dok Hyun
    Hong, Yong Sang
    Choi, Chang-Min
    Ahn, Jin-Hee
    Lee, Dae Ho
    Lee, Jae-Lyun
    Ryu, Min-Hee
    Ryoo, Baek-Yeol
    Chang, Heung-Moon
    Kim, Tae Won
    Kim, Sung-Bae
    Kim, Sang-We
    Suh, Cheolwon
    Kang, Yoon-Koo
    Lee, Jungsin
    Bae, Kyun-Seop
    Kim, Yong-Man
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [50] Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies
    von Mehren, Margaret
    Bookman, Michael
    Meropol, Neal J.
    Weiner, Louis M.
    Sherman, Eric
    Li, Jinhui
    Knoblauch, Roland
    Parekh, Trilok
    Cohen, Roger B.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (05) : 1047 - 1055
12345